Fluorometholone/sulfacetamide sodium ophthalmic Interactions
There are 43 drugs known to interact with fluorometholone/sulfacetamide sodium ophthalmic, along with 9 disease interactions. Of the total drug interactions, 1 is major, and 42 are moderate.
- View all 43 medications that may interact with fluorometholone/sulfacetamide sodium ophthalmic
- View fluorometholone/sulfacetamide sodium ophthalmic disease interactions (9)
Most frequently checked interactions
View interaction reports for fluorometholone / sulfacetamide sodium ophthalmic and the medicines listed below.
- Depo-Testosterone (testosterone)
- Dramamine (dimenhydrinate)
- Eliquis (apixaban)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Ibuprofen PM (diphenhydramine / ibuprofen)
- Iron Sulfate (ferrous sulfate)
- Maxitrol (dexamethasone / neomycin / polymyxin b ophthalmic)
- Mayzent (siponimod)
- Naproxen Sodium DS (naproxen)
- Pancreatin 4X (pancreatin)
- PreserVision AREDS 2 (multivitamin with minerals)
- Ubrelvy (ubrogepant)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zometa (zoledronic acid)
- Zyrtec (cetirizine)
Fluorometholone/sulfacetamide sodium ophthalmic disease interactions
There are 9 disease interactions with fluorometholone / sulfacetamide sodium ophthalmic which include:
- ocular infections
- ocular toxicities
- hematologic toxicity
- hypersensitivity reactions
- porphyria
- crystalluria
- liver disease
- renal dysfunction
- urinary obstruction
Report options
QR code containing a link to this page
More about fluorometholone / sulfacetamide sodium ophthalmic
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: ophthalmic steroids with anti-infectives
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.